Michael Friedman has/had a position (CEO) at Purdue Pharmaceuticals L.P.

Title CEO
Start Date 2003-00-00
End Date 2007-06-00
Executive yes
Notes Michael Friedman, who retired in June as Purdue's president; general counsel Howard Udell; and former chief medical officer Paul Goldenheim pleaded guilty in May to a misdemeanor count of misbranding the drug for claiming that OxyContin was less addictive and less subject to abuse than other pain medications. They must pay $34.5 million of the $634.5 million fine.
Updated over 5 years ago

Source Links